Psoriasis

What Is Psoriasis?

Psoriasis is a chronic, immune mediated inflammatory condition in which skin cells grow far more rapidly than normal, building up on the skin’s surface faster than they can be shed. This accelerated turnover produces the thick, scaly, well defined plaques most people associate with the condition.¹

While psoriasis is fundamentally a disease of the immune system rather than the skin alone, its most visible effects occur on the skin’s surface. In genetically predisposed individuals, immune signaling becomes dysregulated, triggering the excessive keratinocyte growth and inflammation responsible for psoriasis plaques.¹

Several distinct types of psoriasis exist. Plaque psoriasis, the most common form, produces raised, red patches covered with silvery white scales, typically symmetrically distributed on the elbows, knees, scalp, and trunk. Guttate psoriasis, more common in children and young adults, produces small, drop like red spots and is frequently triggered by a preceding streptococcal throat infection.²

Psoriasis is a chronic, immune mediated, inflammatory disease in which genetic and epigenetic changes result in altered immune function, keratinocyte activation, and hyperproliferation.
National Center for Biotechnology Information

Symptoms

Plaque psoriasis, accounting for the large majority of cases, presents as raised, reddish patches of skin covered with a characteristic silvery white scale, most commonly found on the scalp, elbows, knees, and lower back.¹

Beyond visible skin plaques, many patients experience itching, burning, or soreness in affected areas, and psoriasis can also affect the nails, causing pitting, thickening, or separation of the nail from the nail bed in some individuals.²

Guttate psoriasis produces numerous small, scattered, drop shaped red spots rather than larger plaques, while other, less common forms, including pustular and inverse psoriasis, produce distinct patterns of involvement affecting skin folds or areas with visible pus filled bumps, reflecting the considerable clinical variability seen across the condition.²

Causes

Psoriasis results from dysregulated immune signaling, particularly involving a specific pathway known as the interleukin twenty three and interleukin seventeen axis. Inflammatory dendritic cells within the skin produce interleukin twenty three, which drives expansion of a specific group of immune cells that then release interleukin seventeen, directly promoting the excessive skin cell growth and inflammation characteristic of psoriasis plaques.³

Genetic factors play a substantial role in individual susceptibility, and researchers have identified numerous genetic variants associated with increased psoriasis risk, though genetics alone do not fully explain who develops the condition and who does not.⁴

Environmental triggers can provoke new flares or worsen existing disease in genetically susceptible individuals, including skin injury, certain infections, particularly streptococcal throat infections in the case of guttate psoriasis, specific medications, significant stress, and lifestyle factors such as smoking and heavy alcohol use.⁴

Risk Factors

A family history of psoriasis substantially raises individual risk, reflecting the meaningful genetic component underlying the condition, and psoriasis can affect people of any age, though it most commonly first appears in early adulthood.⁴

Obesity and metabolic syndrome are closely associated with increased psoriasis risk and severity, and this relationship appears to work in both directions, with psoriasis itself also contributing to metabolic and cardiovascular risk over time.⁵

Certain medications, including lithium, some blood pressure medications, and antimalarial drugs, along with significant psychological stress and specific infections, have each been identified as factors capable of triggering new psoriasis onset or worsening existing disease in susceptible individuals.⁴

Complications

Psoriatic arthritis develops in a meaningful proportion of psoriasis patients, causing joint pain, stiffness, and swelling that can progress to permanent joint damage if not adequately treated, making early recognition of joint symptoms in psoriasis patients particularly important.²

Psoriasis is increasingly recognized as a multisystem inflammatory disease associated with a considerably elevated risk of cardiovascular disease, high blood pressure, diabetes, and metabolic syndrome, with this cardiometabolic risk correlating directly with overall psoriasis severity.⁵

Beyond physical comorbidities, psoriasis is also associated with meaningfully increased rates of anxiety and depression, reflecting the significant psychological and social burden that visible, chronic skin disease can place on affected individuals throughout their lives.⁵

Treatment

Topical treatments, including corticosteroids and vitamin D analogues, remain the foundation of management for mild to moderate psoriasis, helping to reduce inflammation and slow the excessive skin cell turnover responsible for plaque formation.²

For moderate to severe psoriasis, biologic medications have transformed treatment outcomes in recent years, specifically targeting the immune pathways driving the disease. Current biologic options include inhibitors of tumor necrosis factor, interleukin seventeen, and interleukin twenty three, each offering meaningfully different efficacy, safety, and onset of action profiles.⁶

Beyond directly improving skin symptoms, biologic therapy has also been shown to meaningfully reduce the risk of psoriatic arthritis progression and, in some studies, positively influence cardiometabolic comorbidities, though these medications also carry increased infection risk that requires careful monitoring and coordination between dermatology and other medical specialties.⁷

Prevention

Because psoriasis has a substantial genetic component, there is no proven way to prevent the condition from developing in someone predisposed to it, though identifying and avoiding personal triggers can meaningfully reduce flare frequency and severity once diagnosed.⁴

Maintaining a healthy weight, managing stress, avoiding tobacco, and limiting alcohol intake all appear to reduce both psoriasis severity and the elevated cardiometabolic risk associated with the condition, offering meaningful benefit beyond skin symptoms alone.⁵

For patients already diagnosed, consistent adherence to prescribed treatment, along with regular monitoring for joint symptoms and cardiovascular risk factors, helps identify and manage the broader health implications of psoriasis before they progress to more serious complications.⁵

Why Visual Communication Matters for Psoriasis

Explaining why psoriasis is fundamentally an immune system disease rather than simply a skin condition, or how biologic medications target specific inflammatory pathways to control disease throughout the body, requires visuals that connect visible skin changes to the underlying immunology driving them.¹

Pharmaceutical companies, dermatology and rheumatology practices, and patient advocacy organizations rely on precise illustration and animation to explain psoriasis biology and the rapidly evolving landscape of available treatments.

• Illustrating the interleukin twenty three and seventeen pathway driving psoriasis inflammation
• Animating how excessive keratinocyte turnover produces characteristic psoriasis plaques
• Explaining the connection between psoriasis, psoriatic arthritis, and cardiometabolic disease
• Visualizing the mechanism of action for different classes of biologic therapy
• Supporting patient education on trigger identification and comorbidity awareness
• Creating training materials for clinicians on treatment selection and monitoring

How Biotic Artlab Supports Psoriasis Communication

We work with pharmaceutical companies, dermatology and rheumatology practices, and patient advocacy organizations to create accurate, engaging visuals that make the immunology of psoriasis and its treatment easier to understand for patients and clinicians.

• Custom 3D animations of immune signaling pathways underlying psoriasis
• Detailed illustrations comparing different psoriasis subtypes and presentations
• Mechanism of action animations for topical and biologic therapies
• Patient facing educational materials on comorbidity awareness and management
• Clinical training content for dermatology and rheumatology teams
• Conference presentations and marketing visuals for dermatology audiences

Frequently Asked Questions

Is psoriasis contagious?

No. Psoriasis is an immune mediated condition, not an infection, and cannot be spread from person to person through skin contact.¹

Is psoriasis just a skin condition?

No. Psoriasis is increasingly understood as a systemic inflammatory disease associated with psoriatic arthritis, cardiovascular disease, diabetes, and metabolic syndrome, extending well beyond its visible skin symptoms.⁵

What triggers a psoriasis flare?

Common triggers include skin injury, certain infections, stress, specific medications, smoking, and alcohol use, though triggers vary considerably between individuals and are not always identifiable.⁴

How have biologic medications changed psoriasis treatment?

Biologics targeting specific immune pathways, particularly interleukin seventeen and twenty three, have significantly improved outcomes for moderate to severe psoriasis, offering better skin clearance and reduced risk of complications such as psoriatic arthritis compared with older treatments.⁶

Can psoriasis affect the joints?

Yes. Psoriatic arthritis develops in a meaningful proportion of psoriasis patients, causing joint pain, stiffness, and swelling that can lead to permanent damage without appropriate treatment, making joint symptom awareness important for anyone with psoriasis.²

Does psoriasis increase cardiovascular risk?

Yes. Psoriasis is associated with elevated risk of cardiovascular disease, high blood pressure, and metabolic syndrome, with this risk correlating with overall disease severity, making cardiovascular risk monitoring an important part of ongoing psoriasis care.⁵

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to psoriasis or immune mediated skin disease, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Psoriasis, Symptoms, Causes, and Risk Factors.
2. American Academy of Dermatology. Psoriasis Treatment, Biologics.
3. National Center for Biotechnology Information. Role of the IL 23/IL 17 Axis in Psoriasis and Psoriatic Arthritis, The Clinical Importance of Its Divergence in Skin and Joints.
4. National Center for Biotechnology Information. Macrophage Migration Inhibitory Factor Gene Polymorphisms Confer Risk of Plaque Psoriasis, A Case Control Study.
5. National Center for Biotechnology Information. Cardiometabolic Comorbidities in Patients With Psoriasis, Focusing on Risk, Biological Therapy, and Pathogenesis.
6. National Center for Biotechnology Information. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities, A Literature Review.
7. National Center for Biotechnology Information. Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients With Moderate Severe Psoriasis and Concomitant Diseases.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.